Literature DB >> 23842648

Neuronal network plasticity and recovery from depression.

Eero Castrén1.   

Abstract

The brain processes sensory information in neuronal networks that are shaped by experience, particularly during early life, to optimally represent the internal and external milieu. Recent surprising findings have revealed that antidepressant drugs reactivate a window of juvenile-like plasticity in the adult cortex. When antidepressant-induced plasticity was combined with appropriate rehabilitation, it brought about a functional recovery of abnormally wired neuronal networks. These observations suggest that antidepressants act permissively to facilitate environmental influence on neuronal network reorganization and so provide a plausible neurobiological explanation for the enhanced effect of combining antidepressant treatment with psychotherapy. The results emphasize that pharmacological and psychological treatments of mood disorders are closely entwined: the effect of antidepressant-induced plasticity is facilitated by rehabilitation, such as psychotherapy, that guides the plastic networks, and psychotherapy benefits from the enhanced plasticity provided by the drug treatment. Optimized combinations of pharmacological and psychological treatments might help make best use of existing antidepressant drugs and reduce the number of treatment-resistant patients. The network hypothesis of antidepressant action presented here proposes that recovery from depression and related mood disorders is a gradual process that develops slowly and is facilitated by structured guidance and rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23842648     DOI: 10.1001/jamapsychiatry.2013.1

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  54 in total

1.  ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings.

Authors:  Ian Kodish; Carol M Rockhill; Sara J Webb
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 2.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

Review 3.  Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.

Authors:  Ronald S Duman
Journal:  Depress Anxiety       Date:  2014-03-10       Impact factor: 6.505

Review 4.  Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteins.

Authors:  Tam T Quach; Jessica K Lerch; Jerome Honnorat; Rajesh Khanna; Anne-Marie Duchemin
Journal:  World J Psychiatry       Date:  2016-03-22

Review 5.  Influence of pharmacological and epigenetic factors to suppress neurotrophic factors and enhance neural plasticity in stress and mood disorders.

Authors:  Shashikanta Tarai; Rupsha Mukherjee; Sharda Gupta; Albert A Rizvanov; Andras Palotás; V S Chandrasekhar Pammi; Arindam Bit
Journal:  Cogn Neurodyn       Date:  2019-02-01       Impact factor: 5.082

Review 6.  Sleep, insomnia, and depression.

Authors:  Dieter Riemann; Lukas B Krone; Katharina Wulff; Christoph Nissen
Journal:  Neuropsychopharmacology       Date:  2019-05-09       Impact factor: 7.853

Review 7.  Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.

Authors:  Samuel T Wilkinson; Paul E Holtzheimer; Shan Gao; David S Kirwin; Rebecca B Price
Journal:  Biol Psychiatry       Date:  2018-09-20       Impact factor: 13.382

8.  Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain.

Authors:  David Elmenhorst; Eva-Maria Elmenhorst; Eva Hennecke; Tina Kroll; Andreas Matusch; Daniel Aeschbach; Andreas Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

Review 9.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

Review 10.  Multistage drug effects of ketamine in the treatment of major depression.

Authors:  Martin Walter; Shijia Li; Liliana Ramona Demenescu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-13       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.